Biodegradable NIR‐II Pseudo Conjugate Polymeric Nanoparticles Amplify Photodynamic Immunotherapy via Alleviation of Tumor Hypoxia and Tumor‐Associated Macrophage Reprogramming
Advanced Materials · 2023
DOI: 10.1002/adma.202209799 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2023. Verfasst von Jia Wan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, P. R. China. Hauptthemen laut MEDLINE: Photochemotherapy, Nanoparticles, Neoplasms. Die Arbeit wurde bisher 120-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hunan Province Outstanding Youth Fund.
Abstract (Originalsprache)
Photodynamic therapy (PDT) has achieved great success in cancer treatment. Despite its great promise, the efficacy of photodynamic immunotherapy can be limited by the hypoxia in solid tumors which is closely related to the abnormal tumor vasculature. These abnormal vasculatures are a hallmark of most solid tumors and facilitate immune evasion. Therefore, tumor vascular normalization is developed as a promising strategy to overcome tumor hypoxia, resulting in improved cancer therapy. Here, a NIR‐II bio‐degradable pseudo‐conjugate polymer (PSP)‐based photodynamic polymer is designed to deliver a vascular normalization agent, i.e., regorafenib (Reg) in nanoparticles (NP‐PDT@Reg). NP‐PDT@Reg under 808 nm laser irradiation (NP‐PDT@Reg + L) can efficiently release Reg to improve the tumor hypoxia via vascular normalization, making more NP‐PDT@Reg and oxygen enter the tumors. Moreover, NP‐PDT@Reg + L can further result in generation of more reactive oxygen species (ROS) to eradicate tumor cells while inducing immunogenic cell death (ICD) to activate anti‐tumor immune responses. In addition, Reg can reprogram TAM from a pro‐tumor M2 phenotype to a tumor‐killing M1 phenotype as well, thereby reversing the immunosuppressive tumor microenvironment. Taken together, the current study provides an innovative perspective on the development of novel nanomaterials to overcome the limitations in photodynamic immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, P. R. China.
- Beijing National Laboratory for Molecular Sciences, State Key Laboratory of Polymer Physics and Chemistry, Institute of Chemistry, Chinese Academy of Sciences, Beijing, 100190, P. R. China.
ORCID-Profile: Haihua Xiao
Förderung
- National Natural Science Foundation of China
- Hunan Province Outstanding Youth Fund
Zitieren
APA
Wan, J., Zhang, X., Tang, D., Liu, T., & Xiao, H. (2023). Biodegradable NIR‐II Pseudo Conjugate Polymeric Nanoparticles Amplify Photodynamic Immunotherapy via Alleviation of Tumor Hypoxia and Tumor‐Associated Macrophage Reprogramming. Advanced Materials. https://doi.org/10.1002/adma.202209799
Vancouver
Wan J, Zhang X, Tang D, Liu T, Xiao H. Biodegradable NIR‐II Pseudo Conjugate Polymeric Nanoparticles Amplify Photodynamic Immunotherapy via Alleviation of Tumor Hypoxia and Tumor‐Associated Macrophage Reprogramming. Advanced Materials. 2023. doi:10.1002/adma.202209799
BibTeX
@article{Wan2023,
author = {Wan, Jia and Zhang, Xianghong and Tang, Dongsheng and Liu, Tang and Xiao, Haihua},
title = {Biodegradable NIR‐II Pseudo Conjugate Polymeric Nanoparticles Amplify Photodynamic Immunotherapy via Alleviation of Tumor Hypoxia and Tumor‐Associated Macrophage Reprogramming},
journal = {Advanced Materials},
year = {2023},
doi = {10.1002/adma.202209799}
}
EUVIMED